The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis

Li,Hai; Qiu,Zhenwei; Li,Feng; Wang,Chunlei

doi:10.3892/ol.2017.6924

The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis

Authors:
- Hai Li
- Zhenwei Qiu
- Feng Li
- Chunlei Wang
View Affiliations

Affiliations: Department of General Surgery, Yidu Central Hospital of Weifang, Weifang, Shandong 262500, P.R. China, Department of General Surgery, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: September 13, 2017 https://doi.org/10.3892/ol.2017.6924
Pages: 5865-5870
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The relationship between the expression levels of matrix metalloproteinase‑2 (MMP‑2) and MMP‑9 and breast cancer prognosis was studied. Two breast cancer cell lines (MDA‑MB‑231 and MCF‑7) and one human normal breast cell line (HS578Bst) were investigated. Fluorescence real‑time reverse transcription-polymerase chain reaction (RT‑PCR) and western blotting were used to detect cellular mRNA and protein MMP‑2 and MMP‑9 expression levels. Breast cancer tissue samples from 80 patients and tumor‑adjacent normal tissue samples from 40 patients were collected, and MMP‑2 and MMP‑9 expression in these samples were examined using immunohistochemistry (IHC). The relationship of MMP‑2 and MMP‑9 expression levels with breast cancer patient clinicopathological parameters and prognosis was analyzed. RT‑PCR and western blot results showed that MMP‑2 and MMP‑9 mRNA and protein expression levels were significantly higher in MDA‑MB‑231 and MCF‑7 cells than in HS578Bst cells. A high expression of MMP‑2 and MMP‑9 was found in 83.75% (67/80) and 78.75% (63/80) of breast cancer tissue samples, respectively. MMP‑2 and MMP‑9 expression in breast cancer tissues were significantly different from that in tumor‑adjacent normal tissues (p<0.01). MMP‑2 and MMP‑9 expression levels in breast cancer tissues were correlated with lymph node metastasis and tumor staging. Single factor survival analysis showed that MMP‑2 and MMP‑9 were factors influencing breast cancer prognosis. MMP‑2 and MMP‑9 are highly expressed in breast cancer tissues and are closely related to lymph node metastasis and tumor staging. MMP‑2 and MMP‑9 can be used as reference indices for guiding breast cancer prognosis and treatment.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Garcia-Murillas I, Schiavon G, Weigelt B, Ng C, Hrebien S, Cutts RJ, Cheang M, Osin P, Nerurkar A, Kozarewa I, et al: Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Transl Med. 7:302ra1332015. View Article : Google Scholar : PubMed/NCBI
3	Im NK, Jang WJ, Jeong CH and Jeong GS: Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-κB activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells. J Med Food. 17:855–861. 2014. View Article : Google Scholar : PubMed/NCBI
4	Shalaby MA, Nounou HA, Ms A, O A, Azzam N and Saeed HM: Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the Saudi population. Asian Pac J Cancer Prev. 15:4989–4994. 2014. View Article : Google Scholar : PubMed/NCBI
5	Zhou R, Xu L, Ye M, Liao M, Du H and Chen H: Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Horm Metab Res. 46:753–760. 2014. View Article : Google Scholar : PubMed/NCBI
6	Chia CY, Kumari U and Casey PJ: Breast cancer cell invasion mediated by Gα12 signaling involves expression of interleukins-6 and −8, and matrix metalloproteinase-2. J Mol Signal. 9:62014. View Article : Google Scholar : PubMed/NCBI
7	Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Wey JS, Parikh AA, Fan F, Reinmuth N, Kawaguchi M, Bucana CD, et al: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res. 63:3370–3377. 2003.PubMed/NCBI
8	Zhang W, Wang F, Xu P, Miao C, Zeng X, Cui X, Lu C, Xie H, Yin H, Chen F, et al: Perfluorooctanoic acid stimulates breast cancer cells invasion and up-regulates matrix metalloproteinase-2/-9 expression mediated by activating NF-κB. Toxicol Lett. 229:118–125. 2014. View Article : Google Scholar : PubMed/NCBI
9	Iochmann S, Bléchet C, Chabot V, Saulnier A, Amini A, Gaud G, Gruel Y and Reverdiau P: Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion. Clin Exp Metastasis. 26:457–467. 2009. View Article : Google Scholar : PubMed/NCBI
10	Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J and Treska V: Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Anticancer Res. 29:2513–2517. 2009.PubMed/NCBI
11	Huang S, Chen J and Jia Y: Research on the correlation of MMP9 and p53 expression with the prognosis of triple negative breast cancer. Xiandai Shengwu Yixue Jinzhan. 14:881–884. 2014.
12	Choi JS, Baek HM, Kim S, Kim MJ, Youk JH, Moon HJ, Kim EK and Nam YK: Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy. PLoS One. 8:e838662013. View Article : Google Scholar : PubMed/NCBI
13	Yari K and Rahimi Z, Moradi MT and Rahimi Z: The MMP-2 −735 C allele is a risk factor for susceptibility to breast cancer. Asian Pac J Cancer Prev. 15:6199–6203. 2014. View Article : Google Scholar : PubMed/NCBI
14	Fernandez-Garcia B, Eiró N, Marín L, González-Reyes S, González LO, Lamelas ML and Vizoso FJ: Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology. 64:512–522. 2014. View Article : Google Scholar : PubMed/NCBI
15	Li H, Huang J, Yang B, Xiang T, Yin X, Peng W, Cheng W, Wan J, Luo F, Li H, et al: Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicol Appl Pharmacol. 272:180–190. 2013. View Article : Google Scholar : PubMed/NCBI
16	Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA and Steele RJ: Gelatinase (MMP-2 and −9) expression in gastrointestinal malignancy. Br J Cancer. 78:1495–1502. 1998. View Article : Google Scholar : PubMed/NCBI
17	Bucan V, Mandel K, Bertram C, Lazaridis A, Reimers K, Park-Simon TW, Vogt PM and Hass R: LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells. Genes Cells. 17:559–567. 2012. View Article : Google Scholar : PubMed/NCBI
18	Katunina AI, Gershtein ES, Ermilova VD, Tereshkina IV, Nazarenko AY, Tyleuova AA, Dvorova EK, Karabekova ZK, Gritskevich MV and Berezov TT: Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer. Bull Exp Biol Med. 151:359–362. 2011. View Article : Google Scholar : PubMed/NCBI
19	Rahko E, Jukkola A, Melkko J, Paavo P, Bloigu R, Talvensaari-Mattila A and Turpeenniemi-Hujanen T: Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy. Anticancer Res. 24:4247–4253. 2004.PubMed/NCBI
20	Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS, Di GH, Liu G, Li FM, Ou ZL, et al: Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res Treat. 88:75–85. 2004. View Article : Google Scholar : PubMed/NCBI
21	Jones JL, Glynn P and Walker RA: Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol. 189:161–168. 1999. View Article : Google Scholar : PubMed/NCBI
22	Lebeau A, Müller-Aufdemkamp C, Allmacher C, Sauer U, Nerlich A, Lichtinghagen R and Löhrs U: Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, −3 and −9 in human breast cancer: Correlation with tumour growth. J Mol Histol. 35:443–455. 2004. View Article : Google Scholar : PubMed/NCBI